Voyager Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 37 U.S.-traded ETFs. VYGR has around 2.8M shares in the U.S. ETF market. The largest ETF holder of VYGR is the SPDR S&P Biotech ETF (XBI), with approximately 912.48K shares. Investors may also find of interest that the ETF with the largest allocation to VYGR stock is Invesco Raymond James SB-1 Equity ETF (RYJ), with a portfolio weight of 0.68%. On average, U.S. ETFs allocate 0.09% of VYGR to their portfolios.
Additionally, VYGR is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VYGR as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.